Skip to main content

Table 3 Potential drugs with therapeutic potential for ulcerative colitis-associated colorectal cancer

From: A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis

Cmap name Mean N Enrichment score p Specificity score Percent non-null
Metronidazole  − 0.37 5  − 0.836 0.00032 0 80
3-Acetamidocoumarin  − 0.252 4  − 0.819 0.00203 0.039 50
Heptaminol  − 0.281 5  − 0.735 0.00272 0.0206 60
Isometheptene  − 0.23 4  − 0.799 0.00322 0.0138 50
  1. Mean, average connectivity score; N number of instances